Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abiraterone, absorptiometry, abuse, aggressive, anamorelin, appealed, arbitrage, biosynthetic, cap, ceiling, circulating, clarity, coadministered, Coast, component, Council, CRPC, defense, depot, disproportionate, duration, enobosarm, faith, false, FFS, flare, formulary, fraudulent, FSS, GAAP, Guard, hedge, hedging, Helsinn, highlight, indentified, inflation, insulin, kinase, knowingly, light, loading, mandate, MDV, Medivation, Memorandum, military, Millennium, modification, needy, notification, NSCLC, NV, occupancy, OstarineTMor, Overview, path, penalty, pertinent, PHS, preceding, prednisone, promptly, punishable, QTc, rebate, remuneration, retail, scrutiny, South, stem, strongest, sunshine, Sweden, syncope, tachycardia, Takeda, TRICARE, tubulin, tyrosine, unanticipated, unconstitutional, undergone, unnecessary, upheld, USAN, ventricular, void, walk, willingly, Zytiga
Removed:
ablation, absence, Actonel, afforded, anticipating, arrhythmia, arrythmia, assumed, attributable, Avodart, back, Bazett, beam, belief, bioequivalence, bleeding, BMD, Boehringer, brain, broaden, capacity, cardiac, Carolina, castrated, Chapel, cholesterol, collaborate, collectively, convertible, cooperate, corrected, database, deep, deliverable, denosumab, designated, durable, Effexor, embolism, Emerging, employed, ending, enlargement, estate, estimating, estrogenic, evaluable, Evista, experiencing, extremity, faced, FASB, fatal, female, femoral, femur, FIN, formula, Fosamax, frequent, furniture, Gamble, half, HDL, heart, hematology, highest, Hill, hip, Historically, immobilization, imperfect, Importantly, improved, induced, infrastructure, Ingelheim, inherently, inhibiting, initiate, Investmentsin, John, Karr, launched, LDL, liable, lumbar, man, marker, memory, mentioned, Mexico, mitigate, month, morbidity, morphometric, mortality, moxifloxacin, neck, negotiation, onForm, Ostarine, parallel, pharmacovigilance, PIN, planned, point, post, prespecified, prevalent, problem, Procter, projecting, protected, protracted, pulmonary, QT, QTcB, radiation, radiograph, raloxifene, rare, ratable, reached, real, recurrent, redeemable, redemption, reevaluated, relied, Rev, routine, scanning, semen, showed, showing, slightly, spine, spite, statistically, stimulating, substantiate, surgical, surrogate, Task, tolerated, turmoil, undelivered, undergoing, understand, unintended, unprecedented, vein, vertebral, VTE, yielded, Zometa
Filing tables
Filing exhibits
Related press release
ONCT similar filings
Filing view
External links
Exhibit 10.60
2012 Compensation Information for Registrant’s Executive Officers
The table below provides information regarding (i) the base salary of each executive officer of GTx, Inc. (the “Company”), effective as of January 1, 2012, and (ii) the target cash bonus award for each of the Company’s executive officers under the Company’s Executive Bonus Compensation Plan for fiscal 2012, expressed as a percentage of applicable base salary:
Executive Officer | Title | 2012 Annual Base Salary ($) | 2012 Target Bonus (%) | |||||||
Mitchell S. Steiner | Chief Executive Officer and Vice-Chairman of the Board | 546,000 | 65 | |||||||
Mark E. Mosteller | Vice President, Chief Financial Officer and Treasurer | 310,006 | 30 | |||||||
Marc S. Hanover | President and Chief Operating Officer | 475,020 | 55 | |||||||
Ronald A. Morton, Jr. | Vice President, Chief Medical Officer | 470,106 | 1 | 30 | ||||||
James T. Dalton | Vice President, Preclinical Research and Development | 416,000 | 30 | |||||||
Henry P. Doggrell | Vice President, General Counsel and Secretary | 351,281 | 30 |
1 | Dr. Morton will also be eligible for tax gross-up payments related to certain travel expenses paid by the Company during 2012 on his behalf. |